This Device Evaluation webcast is being made available to the general public. Contact us to learn about everything the Device Evaluation group can do for your organization.
This webcast was held on June 23, 2022. A recording of the event appears below.
Overview
Continuous positive airway pressure (CPAP) therapy is a common treatment for obstructive sleep apnea. In June 2021, Philips Respironics announced a recall that affected millions of their CPAP patients, who may be chronically exposed to fragments of foam and volatile gaseous compounds. While waiting for Philips to provide a full solution, patients are seeking solutions from sometimes questionable sources.
View a recording of our June 23, 2022, live webcast that outlines the issues and provides recommendations for helping your patients.
Presenters
-
Jason Launders, Director of Operations, Device Evaluation, ECRI
-
Ismael Cordero, Senior Project Engineer, Device Evaluation, ECRI
-
Brad Bonnette, Senior Project Officer, Device Evaluation, ECRI
-
Larry J. Hopper, System Director for Respiratory Therapy, Baptist Memorial Hospital Care; Director of Respiratory Therapy, BMH Memphis
View a recording from the June 23, 2022, live-streamed lab webcast, "Helping Patients with Recalled Philips CPAP Devices Used in Home." Length: 0:00.
Play
Poll Results
FDA Links
Original recall (June 2021): Certain Philips Respironics Ventilators, BiPAP, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication
Update (May 2022): Update: Certain Philips Respironics Ventilators, BiPAP Machines, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety Communication
FDA order to Philips Respironics (March 2022): FDA Orders Philips Respironics to Notify Patients Regarding the Recall of Certain Breathing Assistance Machines
Philips Information
Medical Device Recall Information: Philips Respironics Sleep and Respiratory Care devices
ECRI Resources
Technology Background—Including List of Alternative CPAP Devices
Continuous Positive Airway Pressure (CPAP) Units
Resource Collection
Respiratory Assistance Technologies: The Essentials
ECRI Alerts
Philips—CPAP and BiLevel PAP Devices and Mechanical Ventilators: Inhalation of Particles and Volatile Organic Compounds from Sound Abatement Foam May Cause Patient Harm [Update]. Accession No. A37110 04. 2022 May 20.
Philips—CPAP and BiLevel PAP Devices and Mechanical Ventilators: FDA Provides Information Regarding Health Risks Caused by Sound Abatement Foam [Update] [FDA Class I]. Accession No. A37110 03. 2022 Feb 3.
Philips—CPAP and BiLevel PAP Devices and Mechanical Ventilators: FDA Provides Information Regarding Health Risks Caused by Sound Abatement Foam [Update]. Accession No. A37110 02. 2022 Feb 1.
Philips—CPAP and BiLevel PAP Devices and Mechanical Ventilators: Inhalation of Particles and Volatile Organic Compounds from Sound Abatement Foam May Cause Patient Harm. Accession No. A37110 01. 2021 Aug 4.
Philips—CPAP and BiLevel PAP Devices and Mechanical Ventilators: Manufacturer Addresses Health Risks Caused by Sound Abatement Foam. Accession No. A37110. 2021 Sep 13.